Condition: Non-small Cell Lung Cancer · Sponsor: Teligene US
This is a Phase 2b, multicenter, open-label study to evaluate the safety and efficacy of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC (Non-resistant Uncommon EGFR Mutations Only, Including L861Q, G719X, and/or S768I)
This description comes directly from the study's public registry record.
Xiaoyang Xia · 805-300-9373 · Xiaoyang.xia@teligene.com
Dawei Zhang · 805-300-1019 · david.zhang@teligene.com
Always discuss trial participation with your own doctor first.
| OPN Healthcare, Inc. | Glendale, California, United States | Recruiting |
| University Cancer & Blood Center | Athens, Georgia, United States | Recruiting |
| Baptist Health | Louisville, Kentucky, United States | Withdrawn |
| University of Maryland Medical Center | Baltimore, Maryland, United States | Recruiting |
| FirstHealth Cancer Center | Pinehurst, North Carolina, United States | Recruiting |
| University of Texas MD Anderson Cancer Center | Houston, Texas, United States | Active Not Recruiting |
| The First Affiliated Hospital of Bengbu Medical College | Bengbu, Anhui, China | Active Not Recruiting |
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing, Beijing Municipality, China | Active Not Recruiting |
| Beijing Cancer Hospital | Beijing, Beijing Municipality, China | Active Not Recruiting |
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | Active Not Recruiting |
| Beijing Chest Hospital | Beijing, Beijing Municipality, China | Active Not Recruiting |
| The Affiliated Cancer Hospital of Chongqin University | Chongqing, Chongqing Municipality, China | Active Not Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05168566